DSM B.V.
Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.
Publicatie datum
06 mrt 2008 - 08:05
Statutaire naam
DSM B.V.
Titel
DSM invests in innovative treatment against infectious diseases
Bericht
DSM Venturing, the corporate venturing unit of Royal DSM N.V., today announced that it has made an equity investment in the Dutch company IQ Therapeutics B.V. The company develops antibody based products for biodefense and for the prevention and treatment of infectious diseases. DSM Venturing will hold a significant minority share in IQ Therapeutics.
Datum laatste update: 09 november 2024